AN2 Therapeutics, Inc. Common Stock
$4.750
USD
Last updated on --.
24h volume192.64K
24h highest4.8600 USD
24h lowest4.4400 USD
24h Price movement+6.74%
ANTX recent prices
24 Hours
+6.74%+$0.3
30 days
+1.08%+$0.05
60 days
+57.38%+$1.710
90 days
+0.00%$0.00
Key data
Previous close4.4500 USD
Market cap137.58M USD
Volume192.64K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount0.65625 USD
Next ex-dividend dateApr 12, 2018
Next payment dateMay 1, 2018
EPS diluted (TTM)-0.96000 USD
Net income (FY)-34.55M USD
Revenue (FY)--
Last report dateMay 11, 2026
About AN2 Therapeutics, Inc. Common Stock
HeadquartersMENLO PARK
Employees (FY)21.00
Net income per employee (FY)-1.65M USD
Listed onNasdaq
ANTX conversion tables
 |  |
|---|---|
| 0.5 ANTX | 2.375 USD |
| 1 ANTX | 4.750 USD |
| 5 ANTX | 23.75 USD |
| 10 ANTX | 47.5 USD |
| |
|---|---|
| 0.5 USD | 0.10526 ANTX |
| 1 USD | 0.21053 ANTX |
| 5 USD | 1.052 ANTX |
| 10 USD | 2.105 ANTX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ANTX is trading at $4.750, +6.74% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ANTX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ANTX is currently trading at $4.750, +6.74% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ANTX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ANTX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ANTX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ANTX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
AN2 Therapeutics, Inc. Common Stock's market cap is currently 137.58M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume192.64K
24h highest4.8600 USD
24h lowest4.4400 USD
24h Price movement+6.74%
Start trade with ANTX Perpetual
Sign up to trade